rs718265

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_014762.4(DHCR24):​c.1026T>C​(p.Ile342Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.688 in 1,612,104 control chromosomes in the GnomAD database, including 385,062 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.66 ( 33909 hom., cov: 32)
Exomes 𝑓: 0.69 ( 351153 hom. )

Consequence

DHCR24
NM_014762.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.67

Publications

34 publications found
Variant links:
Genes affected
DHCR24 (HGNC:2859): (24-dehydrocholesterol reductase) This gene encodes a flavin adenine dinucleotide (FAD)-dependent oxidoreductase which catalyzes the reduction of the delta-24 double bond of sterol intermediates during cholesterol biosynthesis. The protein contains a leader sequence that directs it to the endoplasmic reticulum membrane. Missense mutations in this gene have been associated with desmosterolosis. Also, reduced expression of the gene occurs in the temporal cortex of Alzheimer disease patients and overexpression has been observed in adrenal gland cancer cells. [provided by RefSeq, Jul 2008]
DHCR24 Gene-Disease associations (from GenCC):
  • desmosterolosis
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 1-54854229-A-G is Benign according to our data. Variant chr1-54854229-A-G is described in ClinVar as Benign. ClinVar VariationId is 297654.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.67 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.782 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DHCR24NM_014762.4 linkc.1026T>C p.Ile342Ile synonymous_variant Exon 7 of 9 ENST00000371269.9 NP_055577.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DHCR24ENST00000371269.9 linkc.1026T>C p.Ile342Ile synonymous_variant Exon 7 of 9 1 NM_014762.4 ENSP00000360316.3

Frequencies

GnomAD3 genomes
AF:
0.665
AC:
100905
AN:
151792
Hom.:
33896
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.617
Gnomad AMI
AF:
0.726
Gnomad AMR
AF:
0.621
Gnomad ASJ
AF:
0.693
Gnomad EAS
AF:
0.411
Gnomad SAS
AF:
0.803
Gnomad FIN
AF:
0.756
Gnomad MID
AF:
0.608
Gnomad NFE
AF:
0.697
Gnomad OTH
AF:
0.653
GnomAD2 exomes
AF:
0.662
AC:
164898
AN:
249076
AF XY:
0.677
show subpopulations
Gnomad AFR exome
AF:
0.616
Gnomad AMR exome
AF:
0.537
Gnomad ASJ exome
AF:
0.700
Gnomad EAS exome
AF:
0.398
Gnomad FIN exome
AF:
0.749
Gnomad NFE exome
AF:
0.691
Gnomad OTH exome
AF:
0.654
GnomAD4 exome
AF:
0.691
AC:
1008540
AN:
1460194
Hom.:
351153
Cov.:
42
AF XY:
0.695
AC XY:
504600
AN XY:
726340
show subpopulations
African (AFR)
AF:
0.614
AC:
20560
AN:
33462
American (AMR)
AF:
0.550
AC:
24543
AN:
44628
Ashkenazi Jewish (ASJ)
AF:
0.698
AC:
18213
AN:
26076
East Asian (EAS)
AF:
0.446
AC:
17682
AN:
39682
South Asian (SAS)
AF:
0.800
AC:
68905
AN:
86106
European-Finnish (FIN)
AF:
0.744
AC:
39638
AN:
53282
Middle Eastern (MID)
AF:
0.624
AC:
3596
AN:
5764
European-Non Finnish (NFE)
AF:
0.697
AC:
774699
AN:
1110862
Other (OTH)
AF:
0.675
AC:
40704
AN:
60332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
14560
29121
43681
58242
72802
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19588
39176
58764
78352
97940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.665
AC:
100966
AN:
151910
Hom.:
33909
Cov.:
32
AF XY:
0.670
AC XY:
49757
AN XY:
74244
show subpopulations
African (AFR)
AF:
0.617
AC:
25528
AN:
41366
American (AMR)
AF:
0.620
AC:
9467
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.693
AC:
2404
AN:
3468
East Asian (EAS)
AF:
0.411
AC:
2113
AN:
5138
South Asian (SAS)
AF:
0.803
AC:
3876
AN:
4824
European-Finnish (FIN)
AF:
0.756
AC:
7995
AN:
10572
Middle Eastern (MID)
AF:
0.603
AC:
176
AN:
292
European-Non Finnish (NFE)
AF:
0.697
AC:
47363
AN:
67962
Other (OTH)
AF:
0.656
AC:
1382
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1759
3518
5277
7036
8795
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
806
1612
2418
3224
4030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.675
Hom.:
161850
Bravo
AF:
0.639
Asia WGS
AF:
0.603
AC:
2102
AN:
3478
EpiCase
AF:
0.685
EpiControl
AF:
0.685

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Desmosterolosis Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
CADD
Benign
11
DANN
Benign
0.76
PhyloP100
1.7
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs718265; hg19: chr1-55319902; COSMIC: COSV64875204; COSMIC: COSV64875204; API